CME-Directory

CME-Certified Congress The Ninth International Congress on the Future of Breast Cancer is an international educational and scientific meeting that focuses on the clinical implications of breast cancer genetic and phenotypic subtyping. New data and promising studies that provide information about how to optimally individualize breast cancer therapy will be discussed and controversial issues debated in panel discussions. Strategies for optimizing the use of endocrine therapy, conventional chemotherapy, and targeted therapies will be presented. Evolving diagnostic approaches to identify the driving mutations or pathways in breast cancers will be thoroughly discussed along with the therapies targeting those mutations. Controversial issues in the surgical and radiotherapeutic management of breast cancer will also be discussed and debated. The format will include didactic sessions from thought leaders, question-and-answer panel discussions, and ample time for participant interaction with faculty.